PFE - SA Asks: What's the most attractive biotech stock right now?
2025-10-12 15:37:29 ET
More on BridgeBio Pharma, Immuneering
- BridgeBio Pharma, Inc. (BBIO) Presents at HFSA 2025 - Slideshow
- Immuneering Corporation (IMRX) Special Call - Slideshow
- Immuneering Corporation (IMRX) Discusses Phase 2a Data Update For IMM-1-104 In First-Line Pancreatic Cancer (Transcript)
- Immuneering surges 40% on mid-stage atebimetinib data in pancreatic cancer
- Immuneering announces public offering, $25M private placement with Sanofi; shares up 55%